Redmile Group, LLC Silence Therapeutics PLC Transaction History
Redmile Group, LLC
- $1.28 Billion
- Q4 2024
A detailed history of Redmile Group, LLC transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Redmile Group, LLC holds 2,399,317 shares of SLN stock, worth $11.8 Million. This represents 1.29% of its overall portfolio holdings.
Number of Shares
2,399,317
Previous 1,899,317
26.33%
Holding current value
$11.8 Million
Previous $34.5 Million
52.22%
% of portfolio
1.29%
Previous 2.26%
Shares
4 transactions
Others Institutions Holding SLN
# of Institutions
65Shares Held
24.6MCall Options Held
500Put Options Held
5K-
Tcg Crossover Management, LLC Palo Alto, CA3.03MShares$15 Million3.41% of portfolio
-
Siren, L.L.C. New York, NY2.83MShares$14 Million0.86% of portfolio
-
Lombard Odier Asset Management (Usa) Corp New York, NY1.86MShares$9.15 Million1.01% of portfolio
-
Morgan Stanley New York, NY1.66MShares$8.2 Million0.0% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA1.15MShares$5.66 Million0.47% of portfolio
About Silence Therapeutics plc
- Ticker SLN
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,888,400
- Market Cap $177M
- Description
- Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...